Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Sachiko Mori"'
Autor:
Hiroshi Ueno, Yu Takahashi, Sachiko Mori, Shinji Murakami, Kenta Wani, Yosuke Matsumoto, Motoi Okamoto, Takeshi Ishihara
Publikováno v:
Behavioural Neurology, Vol 2024 (2024)
Mice are social animals that change their behaviour primarily in response to visual, olfactory, and auditory information from conspecifics. Rearing conditions such as cage size and colour are important factors influencing mouse behaviour. In recent y
Externí odkaz:
https://doaj.org/article/143549b8a64a47018ea06519b9e77fd5
Autor:
Tetsuji Miyazaki, Sachiko Mori, Yoko Inoue, Yoshihiro Tanaka, Susumu Yakushiji, Takeshi Ishihara
Publikováno v:
Anxiety Disorder Research. 14:40-46
Autor:
Sachiko Mori
Publikováno v:
Seikei-Kakou. 34:114-117
Autor:
Keisuke Ishizawa, Masaki Imanishi, Ken Konaka, Sachiko Mori, Soji Kakiuchi, Tatsuhiko Saito, Takumi Sakurada, Shuji Fushitani
Publikováno v:
Biological and Pharmaceutical Bulletin. 42:1839-1845
Uridine 5'-diphospho-glucuronosyltransferase (UGT), a metabolic enzyme of irinotecan active metabolite, has two genetic polymorphisms (UGT1A1*6 and UGT1A1*28). In UGT1A1 homozygous or heterozygous patients, metabolism is delayed and the risk of devel
Publikováno v:
Japanese Journal of Complementary and Alternative Medicine. 15:91-101
Autor:
Ken, Konaka, Takumi, Sakurada, Tatsuhiko, Saito, Sachiko, Mori, Masaki, Imanishi, Soji, Kakiuchi, Shuji, Fushitani, Keisuke, Ishizawa
Publikováno v:
Biologicalpharmaceutical bulletin. 42(11)
Uridine 5'-diphospho-glucuronosyltransferase (UGT), a metabolic enzyme of irinotecan active metabolite, has two genetic polymorphisms (UGT1A1*6 and UGT1A1*28). In UGT1A1 homozygous or heterozygous patients, metabolism is delayed and the risk of devel
Autor:
Hiroshi Ishimoto, Noriho Sakamoto, Takashi Kido, Mutsumi Ozasa, Shin Tsutsui, Mayako Mori, Daichi Setoguchi, Shinnosuke Takemoto, Yasushi Obase, Yuji Ishimatsu, Chiharu Tomonaga, Kanako Matsumoto, Sachiko Morisaki, Kiyonori Miura, Hiroshi Mukae
Publikováno v:
BMC Pulmonary Medicine, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, has demonstrated effectiveness in treating ovarian, breast, and other cancers, particularly those with specific molecular subtypes including, but not limited to, BRCA1/2 m
Externí odkaz:
https://doaj.org/article/bbc66205674c44a1a3037f3efb4be317
Autor:
Sachiko Mori
Publikováno v:
International Forum of Psychoanalysis. 27:166-175
I examined a better therapeutic approach for addressing the heart-rending emotional state of a client exposed to serious traumatic experiences during early childhood without experiencing affect att...
Autor:
Hiroaki Tozaka, Sachiko Mori, Masako Mizutani, Midori Endo, Yuko Ikematsu, Mitsuko Yokouchi, Koji Egawa
Publikováno v:
Nurse Education in Practice. 14:674-679
Aim To reveal the prevalence of nursing students with special educational needs in Japan. Method A mail survey of 833 nursing programs was conducted. Nurse educators were asked to report on their program's profiles and the number of extremely difficu
Autor:
Kannika Roongrotwattanasiri, Sachiko Mori, Manabu Nonaka, Toshiaki Yagi, Ruby Pawankar, Satoko Kimura
Publikováno v:
Allergy, Asthma & Immunology Research
Purpose: The pathogenesis of nasal polyposis (NP) is unclear. Eosinophils and mast cells are considered to play important roles in this process. In addition, the levels of Th2-type cells are increased, irrespective of the atopic status of the patient